Key Points
- Director Pierre Breber purchased 4,000 shares at an average price of $104.13 (total $416,520), boosting his stake 44.44% to 13,000 shares valued at about $1.35M, per an SEC filing.
- Clorox beat the quarter with EPS of $0.85 versus $0.78 expected, but revenue fell 18.9% year-over-year; the company set FY2026 guidance of 5.950–6.300 EPS
- Clorox declared a quarterly dividend of $1.24 (annualized $4.96) for a yield of ~4.7%, with an ex-dividend date of Jan 28 and a payout ratio of 77.86%.
The Clorox Company (NYSE:CLX - Get Free Report) Director Pierre Breber bought 4,000 shares of the business's stock in a transaction on Friday, November 21st. The shares were acquired at an average price of $104.13 per share, with a total value of $416,520.00. Following the completion of the purchase, the director directly owned 13,000 shares of the company's stock, valued at approximately $1,353,690. The trade was a 44.44% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink.
Clorox Trading Up 1.8%
Shares of CLX opened at $105.78 on Tuesday. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The Clorox Company has a 52-week low of $98.20 and a 52-week high of $171.37. The firm has a market cap of $12.90 billion, a price-to-earnings ratio of 16.22, a PEG ratio of 0.92 and a beta of 0.52. The business's fifty day moving average is $114.94 and its 200-day moving average is $121.97.
Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings data on Monday, November 3rd. The company reported $0.85 earnings per share for the quarter, beating the consensus estimate of $0.78 by $0.07. The business had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.41 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.Clorox's revenue was down 18.9% compared to the same quarter last year. During the same period last year, the firm posted $1.86 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. Equities analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.
Clorox Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 28th will be given a dividend of $1.24 per share. This represents a $4.96 dividend on an annualized basis and a yield of 4.7%. The ex-dividend date is Wednesday, January 28th. Clorox's dividend payout ratio is currently 77.86%.
Analyst Upgrades and Downgrades
CLX has been the topic of a number of research analyst reports. Weiss Ratings restated a "hold (c-)" rating on shares of Clorox in a research report on Tuesday, October 14th. Wells Fargo & Company dropped their price target on Clorox from $125.00 to $117.00 and set an "equal weight" rating for the company in a research note on Tuesday, November 4th. Barclays cut their price objective on Clorox from $112.00 to $108.00 and set an "underweight" rating on the stock in a report on Tuesday, November 4th. Zacks Research cut Clorox from a "hold" rating to a "strong sell" rating in a report on Tuesday, October 28th. Finally, TD Cowen dropped their target price on Clorox from $120.00 to $117.00 and set a "hold" rating for the company in a research report on Wednesday, October 1st. One equities research analyst has rated the stock with a Buy rating, twelve have given a Hold rating and five have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Reduce" and a consensus price target of $125.69.
Read Our Latest Stock Report on CLX
Institutional Trading of Clorox
Institutional investors and hedge funds have recently bought and sold shares of the stock. Invesco Ltd. lifted its holdings in Clorox by 138.3% during the 2nd quarter. Invesco Ltd. now owns 3,245,175 shares of the company's stock worth $389,648,000 after buying an additional 1,883,465 shares during the period. Norges Bank bought a new position in shares of Clorox during the second quarter worth about $190,429,000. Van ECK Associates Corp lifted its stake in shares of Clorox by 93.9% in the third quarter. Van ECK Associates Corp now owns 2,709,972 shares of the company's stock worth $334,139,000 after acquiring an additional 1,312,471 shares during the period. Arrowstreet Capital Limited Partnership lifted its stake in shares of Clorox by 218.4% in the second quarter. Arrowstreet Capital Limited Partnership now owns 1,249,127 shares of the company's stock worth $149,983,000 after acquiring an additional 856,873 shares during the period. Finally, Worldquant Millennium Advisors LLC bought a new stake in Clorox in the second quarter valued at approximately $71,856,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.
About Clorox
(
Get Free Report)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
